MG

Mahesh Gunvantrao Shelke

Active Director Designated Partner DIN 10905051
DIN 10905051 First appointment Jan 2025 Primary industry Biotechnology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mahesh Gunvantrao Shelke

Data last updated:

Mahesh Gunvantrao Shelke is a Designated Partner at Agrinucleon Biosciences Llp (since 2025). The company operates in Biotechnology.

DIN 10905051
Primary Designation Designated Partner
Industry Biotechnology
First Appointment 13 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner13 Jan 20252025Active

Board colleagues of Mahesh Gunvantrao Shelke

NameDINCompanyDesignation
Rahul Shelke10905052Agrinucleon Biosciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Agrinucleon Biosciences Llp
Premium access

Shareholding and investment profile for Mahesh Gunvantrao Shelke

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahesh Gunvantrao Shelke

Mahesh Gunvantrao Shelke currently holds 1 directorship: Agrinucleon Biosciences Llp (Designated Partner, since 13 Jan 2025).

Mahesh Gunvantrao Shelke was first appointed on 13 Jan 2025 as Designated Partner at Agrinucleon Biosciences Llp.

The current boards of Mahesh Gunvantrao Shelke's companies include Rahul Shelke (Agrinucleon Biosciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available